Mutalysin-II (mut-II) from Lachesis muta snake venom is an endopeptidase with hemorrhagic activity. A mAb against mutalysin-II that neutralized the hemorrhagic effect was produced previously. To identify the mAb epitopes, sets of 15-mer overlapping peptides covering the mut-II amino acid sequence were synthesized using the SPOT method and tested but failed to react with the mAb. Using a phage-display approach seventeen clones reactive with mAb were identified. Additional immunoassays with the peptides and mAb identified the QCTMDQGRLRCR, TCATDQGRLRCT, HCFHDQGRVRCA, HCTMDQGRLRCR and SCMLDQGRSRCR sequences as possible epitopes. Immunization of rabbits with these peptides induced antibodies that recognize mut-II and protected against the hemorrhagic effects of Lachesis venom.
Introduction
Snake bites are an important public health problem in Brazil. Approximately 20,000 cases are reported annually, with a mortality rate of 0.5%. Envenomation due to Bothrops sp. and Lachesis muta accounts for more than 80% of cases [30] . Local or invasive hemorrhage is a major complication of Bothrops and Lachesis envenomation; this results from the action of hemorrhagic metalloproteinases, also referred to as reprolysins [4] . In addition, there are secondary factors which are involved in blood coagulation disorders, kinin release and also neurotoxic components [22, 23] .
Metalloproteinases from viperid snake venoms (SVMPs) disrupt the vascular basement membrane resulting in typical hemorrhage [4, 33] . As observed in other snakes, envenoming by the bushmaster snake (L. muta muta) leads to the development of both local and systemic bleeding. Two hemorrhagic factors characterized as metalloproteinases were named LHF-I and LHF-II (Lachesis hemorrhagic factor I and II), and correspond to mutalysin-I and mutalysin-II (mut-II), respectively [35] . Mutalysin-I is a large pep-tidase (100 kDa) with restricted substrate specificity and has the strongest hemorrhagic activity (approximately 30 times higher than mut-II). Mut-II is a 22.5 kDa single chain protein with broad substrate specificity and traces of hemorrhagic effects [35, 36] . As for other SVMPs, mutalysins proteolytically degrade not only fibrinogen, but also other extracellular matrix components such as laminin, fibronectin, type IV collagen or gelatin [34, 35] . In addition, mutalysin-I selectively inhibits collagen-induced aggregation of human platelets [12] .
We have previously reported that the monoclonal antibody LmmAbB2D4 [11] and rabbit polyclonal antibodies [39] against mut-II show cross-reactivity against mutalysin-I and efficiently neutralize the hemorrhagic effects of whole L. muta muta venom and certain Bothrops venoms (i.e. B. alternatus, B. atrox, B. itapetiningae, B. jararaca and B. neuwiedii). Identifying the epitope of this neutralizing antibody could aid in the preparation of immunogens for therapeutic serum development or vaccination approaches. In the present investigation, the peptide phage-display method [20, 40] , and the SPOT synthesis technique [17, 26, 31] were used together to identify the epitope recognized by LmmAbB2D4. Rabbits immunized with defined synthetic mimotopes encapsulated in liposomes produced an antibody response capable of efficiently neutralizing the hemorrhagic effect of L. muta crude venom. 
Materials and methods

Animals, L. muta muta snake venom and antibodies
Eight-to nine-week-old New Zealand rabbits were maintained at the Centro de Bioterismo, ICB-UFMG (Belo Horizonte, MG, Brazil), and received water and food under controlled environmental conditions. Treatment and handling of all animals used in the experiments followed the requirements of the Ethics Committee of Animal Experimentation (CETEA) of UFMG. The L. muta muta venom was obtained by milking specimens captured near Manaus, Amazonas, Brazil and raised at the serpentarium of Fundaç ão Ezequiel Dias (FUNED), Belo Horizonte, Brazil. Mut-II was isolated as previously described by Sanchez et al. [36] . The neutralizing monoclonal antibody (LmmAbB2D4) and the polyclonal antibodies against mut-II were produced as described by Estêvão-Costa et al. [11] and Souza et al. [39] , respectively.
Spot synthesis
Overlapping synthetic peptides corresponding to the mut-II amino acid sequence (GenBank accession number AAQ16123) were prepared using the SPOT technique [17] . Two series of membrane-bound peptides were synthesized according to the procedure described by Laune et al. [26] as 15-mer peptides frameshifted by three residues. After synthesis, nonspecific binding sites of the membranes were blocked by incubation with blocking buffer (Roche, Germany) overnight at 4 • C, and further probed with rabbit serum against mut-II (diluted 1:400) or with LmmAbB2D4 (1 or 10 g/ml in blocking buffer) for 90 min at room temperature. Antibody binding to spots was revealed by incubation (90 min at room temperature) with alkaline phosphatase-conjugated goat anti-rabbit or goat anti-mouse antibodies and 5-bromo-4-chloro-3-indolyl phosphate (BCIP) plus 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) as substrate. The membrane was stripped by sequential treatment with dimethylformamide, 1% SDS, 0.1% 2-mercaptoethanol in 8 M urea, ethanol/water/acetic acid (50:40:10, v/v/v) and, finally, methanol to remove the precipitated dye and molecules bound to the peptides.
Isolation of phage clones binding to LimAb7
Four different M13 phage libraries expressing 15-mer (X 15 ), 30-mer (X 30 ), 17-mer including a fixed cysteine residue (X 8 CX 8 ), and 12-mer peptides including two fixed cysteine residues (XCX 8 CX) were employed [40] . Biopannings were performed as described previously [40] with some modifications. Briefly, 96-well microtiter plates (Becton Dickinson, Oxnard, CA) were incubated overnight at 4 • C with 100 l LmmAbB2D4 at 5 g/ml for the first two biopannings and 0.5 g/ml for the last one, in 0.1 M NaHCO 3 , pH 8.6. The plates were then washed with 0.05% Tween 20 in 50 mM Trisbuffered saline, pH 7.5 (TBS-T) and blocked with 3% BSA in TBS-T at 37 • C for 2 h. For the first biopanning, 1.5 × 10 11 transducing units (TU) of phages expressing linear 15-mer (X15), 17-mer (X 8 CX 8 ) and 30-mer (X 30 ) peptides and 2.5 × 10 10 TU of phages expressing constrained 12-mer (XCX 8 CX) peptides were incubated in TBS-T with the immobilized LmmAbB2D4 overnight at 4 • C. Unbound phages were removed by washing with TBS-T. Bound phages were eluted with 0.1 M glycine, 1 mg/ml bovine serum albumin (pH 2.2) and neutralized with 2 M Tris-HCl, pH 9.0. Escherichia coli K91 cells were infected with the eluted phages and grown overnight at 37 • C. Phage particles were precipitated with 20% PEG 8000, 2.5 M NaCl overnight on ice, resuspended in 0.05 M Tris-HCl, 0.15 M NaCl, pH 7.5 and used for the next round of biopanning (2 × 10 11 TU). After three rounds, phage clones were isolated and submitted to screening ELISA.
Sandwich ELISA screening assay
Microtiter plate wells (Falcon) were coated with 100 l sheep anti-M13 polyclonal antibody (10 g/ml) in 0.1 M NaHCO 3 , pH 8.6, overnight at 4 • C. Plates were washed with 0.1% Tween 20-PBS (PBS-T) and blocked with 2% non-fat dry milk in PBS-T for 1 h at 37 • C. The wells were washed, and phages, diluted 1:1 in PBS-T, were incubated for 90 min at 37 • C. Phages able to bind LmmAbB2D4 at 10 g/ml were detected by a horseradish peroxidise (HRP)-conjugated rabbit anti-mouse antibody (Sigma, St. Louis, MO, USA). The clones selected by LmmAbB2D4 were used in a new ELISA plate configuration to verify their reactivity with the monoclonal antibody. Plates were sensitized with 5 g/ml LmmAbB2D4 in coating buffer, washed and blocked as described previously and incubated with phages at 1 × 10 11 to 1 × 10 6 pfu/ml diluted in 0.05% Tween 20-PBS for 2 h at 37 • C. Binding was detected using a HRP-conjugated anti-M13 antibody (Sigma) diluted 1:3000 in blocking buffer.
DNA sequencing, peptides synthesis on cellulose membranes and immunoassay
The single-stranded DNA was purified using the QIAprep Spin M13 protocol (Qiagen). Sequencing reactions were carried out according to the dideoxy chain termination method using the ABI Prism Kit using the ABI PRISM 377 (both from PE Applied Biosystems). The reverse primer 5 -TCGGCAAGCTCTTTTAGG-3 was used for sequencing. The sequences obtained were translated and seventeen dodecapeptides corresponding to the XCX 8 CX library were identified. A cellulose membrane containing the seventeen peptides was prepared, blocked and probed with LmmAbB2D4 (10 g/ml) as described in Section 2.2.
Synthesis, chromatography and mass spectrometry of soluble peptide
Based on the results of immunoassay with cellulose-bound peptides, the peptides recognized by LmmAbB2D4 (QCTMDQ-GRLRCR, TCATDQGRLRCT, HCFHDQGRVRCA, HCTMDQGRLRCR and SCMLDQGRSRCR) were synthesized manually by Fmoc chemistry [18] . The peptides were deprotected and released from the resin by trifluoroacetic acid (TFA) treatment in the presence of the appropriate scavengers. The peptides were lyophilized and their purity assessed by HPLC and their mass confirmed by mass spectrometry. The synthetic peptides (20 mg of each) were diluted in 1 ml of PBS and used for immunogen preparation. The peptides were purified by high performance liquid chromatography (HPLC) on a C18 reverse phase column (flow rate 1.0 mL/min; Vydac). The column was equilibrated with 0.1% aqueous TFA, and was eluted by a linear gradient of 0.1% TFA in acetonitrile. The peaks were then submitted to MALDI-TOF-TOF analyses. MS and tandem MS analysis were performed using a MALDI-TOF-TOF AutoFlex III (Bruker Daltonics) instrument in positive/reflector mode controlled by the FlexControl software. Instrument calibration was achieved by using Peptide Calibration Standard II (Bruker Daltonics) as reference and ␣-cyano-4-hydroxycinnamic acid was used as the matrix.
Liposome preparation and peptide incorporation
The individual peptides were encapsulated in liposomes using the dehydration-rehydration method [24] . Briefly, multilamellar vesicles (MLVs) were prepared in water from an equimolar mixture of cholesterol (CHOL; Sigma) and egg yolk phosphatidylcholine (EPC, 100%; Lipoid) at a 135 g/L final lipid concentration, through the film hydration method. Small unilamellar vesicles (SUVs) were obtained by submitting the MLVs suspension to three 5 min-cycles of ultrasonication using a probe-sonicator (Misonix) under argon and in an ice-cold bath. After filtration through a sterile 0.22 m membrane, the SUVs suspension was mixed with the peptide solution at a 64:1 lipid-to-peptide mass ratio and the mixture was immediately frozen in liquid nitrogen and then dried overnight (freeze-dryer, 4.5 L; Labconco, UK). Dehydration-rehydration vesicles (DRVs) were obtained through rehydration of the dried powder at 25 • C as follows: one-tenth of the original SUVs volume of deionized water was added, vortexed and incubated for 30 min; 0.1 volume of PBS (0.15 M NaCl, 0.01 M phosphate, pH 7.2) was added, and the mixture was vortexed prior to the addition of 0.8 volume of PBS, and then vortexed again and incubated for 30 min. A parallel preparation of empty (PBS-loaded) DRVs was also obtained. The fraction of peptide entrapped in liposomes was determined indirectly by centrifugation (43,000 × g; 30 min; 4 • C) and peptide titration in the supernatant.
Immunization protocols
Adult female New Zealand white rabbits (2.0-2.5 kg) were used for the production of anti-peptide antibodies. After collection of pre-immune sera, each animal received an initial subcutaneous injection of 100 g liposome-trapped synthetic peptide in aluminum hydroxide (day 1). Five similar booster injections were made 21, 36, 51, 66 and 76 days later. Blood samples were drawn 1 week after the last injection. As a control, rabbits were also immunized with liposomes not containing synthetic peptides, prepared as described previously [9] .
Indirect ELISA for the determination of anti-peptide antibodies
Falcon flexible microtitration plates (Becton Dickinson France S.A.) were coated overnight at 4 • C with 5 g/ml mut-II or L. muta muta whole venom in 0.02 M NaHCO 3 buffer, pH 9.6, as described previously [3] . Absorbance values were determined at 492 nm with a Titertek Multiscan spectrophotometer. Tests were done in triplicate and the values represent means of experiments. Standard deviations are represented by error bars. Results were evaluated by Student's t-test using Sigma Plot 10.0. In all cases, differences were considered significant at P < 0.05.
Toxicity assays
Hemorrhagic activity was assayed using the Kondo method [25] and adapted by Sanchez et al. [36] . Aliquots of L. muta muta venom in 100 l physiological saline, or saline alone, were injected into the dorsal shaved skin of the non-immunized rabbits. Twenty-four hours later, the rabbits were euthanized and the back skin was totally removed in order to photograph and measure the hemorrhagic lesions. One minimum hemorrhagic dose (MHD) was defined as the dose which causes a hemorrhagic lesion 10 mm in diameter. The MHD of L. muta venom used throughout this study was 20 g.
For the in vivo neutralization assays of the hemorrhagic activity of L. muta venom, the immunized and control rabbits were challenged with L. muta venom 30 days after the last immunization by intradermal injection of an amount equivalent to 1 MND/kg.
Results
Epitope mapping
In order to map the epitope recognized by the neutralizing monoclonal antibody LmmAbB2D4, membrane-bound peptides of 15 amino acids, spanning the entire sequence of mut-II, were probed with LmmAbB2D4. Only background reactivity was observed at the highest concentration of the polyclonal antibody (10 g/ml; Fig. 1B  -lower panel) . As a control for peptide quality, the 15-mer peptides (Fig. 1A -upper panel) were reactive when probed with a rabbit polyclonal antiserum produced against mut-II.
The phage-display system of expression of randomly generated peptides can identify peptides mimicking discontinuous epitopes (mimotopes). To identify peptides that would bind to LmmAbB2D4, four different phage libraries were screened, two of which expressed linear peptides of either 15 (X15) or 30 amino acids (X30), whereas the other two displayed peptides including either one or two fixed cysteines and whose sizes were 17 (XCX15) or 12 amino acids (XCX8CX). A significant enrichment of phage binding to the target antibodies was obtained after three rounds of biopanning (data not shown). Of approximately one hundred phage clones randomly picked from the third round of selection, seventeen clones were selected. The DNA sequence and the deduced amino acid sequence were determined ( Fig. 2A) , showing that the peptides were selected from the (XCX8CX) library. Another cellulose membrane containing the seventeen peptides were prepared, blocked and probed with LmmAbB2D4 (10 g/ml). As shown in Fig. 2B , the peptides recognized by LmmAbB2D4 were peptide 4 (QCTMDQGRLRCR), peptide 7 (TCATDQGRLRCT), peptide 8 (HCFHDQGRVRCA), peptide 14 (HCTMDQGRLRCR) and peptide 15 (SCMLDQGRSRCR). Analysis of these sequences revealed no obvious homology between the mimotopes and the mut-II sequence.
Neutralizing ability of anti-peptide antibodies
Based on the results of immunoassay with cellulose-bound peptides, the peptides (QCTMDQGRLRCR, TCATDQGRLRCT, HCFHDQ-GRVRCA and HCTMDQGRLRCR) were synthesized in a soluble form, trapped in liposomes and used as immunogens in rabbits. One week after the sixth injection, sera from rabbits were tested in an indirect ELISA for their reactivity toward the peptides, the L. muta whole venom and the cognate mut-II protein. The sera from rabbits immunized with peptides show marginal reactivity against the peptides coated to plates, likely due to low adsorption of peptides to the microtiter plates (data not shown). However, ELISA reactivity was observed when the antigens were L. muta crude venom and mut-II (Fig. 3A and B) . The strongest reactivity toward Mut-II was obtained with the serum of rabbits immunized with peptides TCAT-DQGRLRCT and QCTMDQGRLRCR (Fig. 3B) . The serum of rabbits immunized with the peptides HCFHDQGRVRCA and HCTMDQGRL-RCR reacted poorly with the Mut-II protein, even lower that the serum of mock-liposomes immunized rabbits.
The neutralizing properties of the anti-peptide antibodies raised in rabbits were assessed in vivo by testing the hemorrhagic inducing activity of L. muta venom in animals immunized with the four target peptides. The rabbits immunized with the peptide-mimotopes TCATDQGRLRCT and QCTMDQGRLRCR were completely protected ( Fig. 4A and B) . The rabbits immunized with the HCFHDQGRVRCA and HCTMDQGRLRCR peptides were partially protected (about 62% and 37% protection, respectively). The animal from the group that received the empty liposome (without peptides) as negative control liposome was not protected.
Discussion
Snake venoms are a cocktail of biologically active molecules, including toxins with enzymatic and non-enzymatic activities that have evolved to assist in the capture and digestion of prey, as well as defense against predators. Human systemic envenomation is associated with a number of adverse effects, the nature and severity of which depends on the species of snake, the quantity of venom injected and the time period between envenomation and the administration of appropriate medical treatment. These effects may include paralysis, myolysis, blood coagulation disturbances and renal damage [7, 41] . Bushmaster snake envenomation is characterized by serious hemorrhage, blood coagulation disorders, and renal failure; hemorrhage is the major complication resulting from envenomation by the pit vipers Bothrops and Lachesis snakebites [22] . Hemorrhagic metalloproteinases are important contributors to local and systemic hemorrhage in human snakebite victims. Two of these metalloproteinases, originally called Lachesis hemorrhagic factors I and II (LHF-I and LHF-II; corresponding to mutalysin-I and mut-II), were previously purified and characterized [37] . Mut-II is a P-I class SVMP single chain protein of 22.5 kDa with broad substrate specificity and a minor hemorrhagic effect [38] . Our previous results showed that the neutralizing monoclonal antibody LmmAbB2D4, produced against L. muta muta venom, recognizes mut-II and neutralizes the hemorrhagic effect of L. muta and several Bothrops crude venoms [11, 39] . However, the ability of LmmAbB2D4 to neutralize the whole venom is likely due to the recognition of several venom proteins that share the same epitopic region [11] . Since several continuous antigenic regions of mut-II were previously identified [15] , herein we mapped the mut-II epitope recognized by LmmAbB2D4 to determine if it corresponds to known antigenic regions. We first used the peptide scanning method to map continuous and discontinuous epitopes [2, 6, 10, 14, 27, 28] . Sets of 15-mer overlapping peptides covering the mut-II amino acid sequence were chemically synthesized by the SPOT method of multiple peptide synthesis [26, 31] . Such linear peptides were, however, not recognized, indicating that the epitope is likely discontinuous. Consequently, the phage-display technique was used. Although libraries of filamentous phages have often led to the identification of peptides with high homology to the wild type sequence of the epitope [8, 13, 32] , we have identified, like others [1, 16, 19] , peptides (mimotopes) mimicking discontinuous components of the epitope. All seventeen identified peptides contain two cysteine residues. Thus, the peptides must be constrained to be recognized, suggesting that the antibody is sensitive to conformation. We note, however, that the peptides QCTMDQGRLRCR, TCATDQ-GRLRCT, HCFHDQGRVRCA, HCTMDQGRLRCR and SCMLDQGRSRCR were able to bind LmmAbB2D4 when prepared as synthetic replicas of the phage-born sequences. This can be due to the different conformations the peptide adopts in the cellulose membranes when it is prepared as a synthetic peptide, compared to the conformations it adopts when displayed on phage surface [29] . The amino acid sequences of the phage-selected peptides had no homology with the sequence of Mut-II protein, and thus are considered mimotopes.
Phage-display peptide libraries have identified mimotopes of toxins from scorpion and snake venoms. Such peptides stimulate the production of neutralizing antibodies [5, 19, 21] . Our results show, for the first time, the usefulness of peptide mimotopes for the neutralization of hemorrhagic activity induced in animals by bushmaster snake venom. Given that synthetic epitopes derived from mut-II sequences permit the development of efficient mut-II antivenom [15] and that two mimotopes are capable of inducing a significant neutralizing humoral response against L. muta muta snake venom, these synthetic immunogens will allow for therapeutic serum development or for vaccination approaches. 
